Brinker Capital Investments’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $371K | Sell |
1,480
-805
| -35% | -$200K | ﹤0.01% | 1576 |
|
|
2025
Q4 | $629K | Sell |
2,285
-304
| -12% | -$83.2K | ﹤0.01% | 1498 |
|
|
2025
Q3 | $679K | Buy |
2,589
+766
| +42% | +$186K | 0.01% | 1412 |
|
|
2025
Q2 | $399K | Sell |
1,823
-1,132
| -38% | -$242K | ﹤0.01% | 1583 |
|
|
2025
Q1 | $662K | Buy |
2,955
+946
| +47% | +$261K | 0.01% | 1278 |
|
|
2024
Q4 | $658K | Sell |
2,009
-29
| -1% | -$9.13K | 0.01% | 1246 |
|
|
2024
Q3 | $612K | Sell |
2,038
-4,029
| -66% | -$1.23M | 0.01% | 1262 |
|
|
2024
Q2 | $2M | Sell |
6,067
-763
| -11% | -$270K | 0.02% | 643 |
|
|
2024
Q1 | $2.7M | Sell |
6,830
-683
| -9% | -$253K | 0.03% | 519 |
|
|
2023
Q4 | $2.64M | Sell |
7,513
-345
| -4% | -$122K | 0.03% | 500 |
|
|
2023
Q3 | $2.95M | Sell |
7,858
-1,074
| -12% | -$415K | 0.04% | 450 |
|
|
2023
Q2 | $3.42M | Buy |
8,932
+95
| +1% | +$33.9K | 0.04% | 436 |
|
|
2023
Q1 | $3.06M | Buy |
8,837
+530
| +6% | +$155K | 0.04% | 419 |
|
|
2022
Q4 | $1.96M | Sell |
8,307
-619
| -7% | -$147K | 0.04% | 491 |
|
|
2022
Q3 | $2.2M | Sell |
8,926
-496
| -5% | -$151K | 0.05% | 422 |
|
|
2022
Q2 | $2.85M | Buy |
9,422
+4,466
| +90% | +$1.45M | 0.05% | 338 |
|
|
2022
Q1 | $2.04M | Buy |
4,956
+3,345
| +208% | +$1.31M | 0.03% | 524 |
|
|
2021
Q4 | $756K | Sell |
1,611
-193
| -11% | -$83.1K | 0.01% | 924 |
|
|
2021
Q3 | $648K | Hold |
1,804
| – | – | 0.01% | 903 |
|
|
2021
Q2 | $648K | Buy |
1,804
+620
| +52% | +$205K | 0.01% | 957 |
|
|
2021
Q1 | $334K | Sell |
1,184
-12,260
| -91% | -$3.51M | 0.01% | 1022 |
|
|
2020
Q4 | $3.81M | Buy |
13,444
+3,101
| +30% | +$870K | 0.06% | 397 |
|
|
2020
Q3 | $2.84M | Buy |
+10,343
| New | +$2.74M | 0.05% | 362 |
|
Other funds holding WST
VCM
VPM
GIM
